GB837965A - Improvements in or relating to amines and to processes for their preparation - Google Patents

Improvements in or relating to amines and to processes for their preparation

Info

Publication number
GB837965A
GB837965A GB32662/57A GB3266257A GB837965A GB 837965 A GB837965 A GB 837965A GB 32662/57 A GB32662/57 A GB 32662/57A GB 3266257 A GB3266257 A GB 3266257A GB 837965 A GB837965 A GB 837965A
Authority
GB
United Kingdom
Prior art keywords
group
methoxyphenoxy
alkyl
primary
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB32662/57A
Inventor
Julius Nicholson Ashley
Raymond Frederick Collins
Michael Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Priority to GB32662/57A priority Critical patent/GB837965A/en
Publication of GB837965A publication Critical patent/GB837965A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises compounds of the formula <FORM:0837965/IV (b)/1> and acid addition salts thereof, wherein R1 and R2 are hydrogen, C1-6 alkyl, or hydroxyalkyl (including polyhydroxyalkyl), B is a hydrocarbon chain of 2 or 3 carbon atoms, saturated or ethylenically unsaturated and optionally bearing lower alkyl substituents, R1 is a C1-4 alkyl or alkoxy group and R3 is hydrogen or a C1-4 alkyl or alkoxy, or primary, secondary or tertiary amino or nitro substituent, preferably in the p-position; and sodium formaldehyde-bisulphite derivatives of the primary amines of the above formula. The compounds are prepared as described in the parent Specification by condensing a compound of the formula <FORM:0837965/IV (b)/2> with a compound <FORM:0837965/IV (b)/3> wherein X is a tertiary amino group NR1R2 or a group convertible to a primary, secondary or tertiary group NR1R2, M is hydrogen or an alkali-metal, B1 is the same as B or is a corresponding less saturated group, Y is the group R3 or an atom or group convertible thereto, Q is the radical of a reactive ester, e.g. methane-sulphonate or halogen and R11 the same as R1 or is a hydroxyl group; followed, if necessary, by conversion of the groups X, Y, B1 and R11 into NR1R2, R3, B and R1. The products are use in the treatment of bilharziasis. Examples describe the preparation of a -(4-amino-2-methoxyphenoxy) - o - phenyl - ethane, - propane and a -methylpropane (methanesulphonate) and a - (4 - dimethylamino - 2 - methoxyphenoxy) - b -phenyl-ethane and a -(4-b -hydroxyethylamino-2 - methoxyphenoxy) - b - phenyl - ethane (hydrobromide). 1 - (2 - Methoxy - 4 - nitrophenoxy) - 2 - phenyl-ethane, 3-phenylpropane and 3-phenyl-1-methyl-propane are made by treating potassium 2-methoxy-4-nitrophenoxide with the appropriate phenylalkyl bromide. 1 - (4 - Dimethylamino - 2 - methoxyphenoxy) - 2-phenylethane methiodide is made by the action of methyl iodide on the primary base. 1 - (4 - b - Chloroethoxycarbonamido - 2 - methoxyphenoxy) - 2 - phenylethane is made by the action of 2-chloroethyl chloroformate on 1-(4-amino-2-methoxyphenoxy)-2-phenylethane.ALSO:Pharmaceutical preparations for the treatment of bilharziasis comprise compounds of the formula <FORM:0837965/VI/1> or acid addition salts thereof, wherein R1 and R2 are hydrogen, C1-6 alkyl or hydroxyalkyl (including polyhydroxyalkyl), B is a hydrocarbon chain of 2 or 3 carbon atoms, saturated or ethylenically unsaturated and optionally bearing lower alkyl substituents, R1 is a C1-4 alkyl or alkoxy group and R3 is hydrogen or a C1-4 alkyl or alkoxy group or a primary, secondary or tertiary amino or a nitro substituent, preferably in the p-position, or a formaldehyde-bisulphite addition product of a primary amine of the above formula, and a pharmaceutical carrier suitable for oral or parenteral administration. The preparations suitably take the form of solutions, suspensions, syrups, elixirs, emulsions, powders or tablets. Suitable excipients for tablets or compressed powders include starch, lactose, stearic acid, magnesium stearate or dextrin.
GB32662/57A 1957-10-18 1957-10-18 Improvements in or relating to amines and to processes for their preparation Expired GB837965A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB32662/57A GB837965A (en) 1957-10-18 1957-10-18 Improvements in or relating to amines and to processes for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB32662/57A GB837965A (en) 1957-10-18 1957-10-18 Improvements in or relating to amines and to processes for their preparation

Publications (1)

Publication Number Publication Date
GB837965A true GB837965A (en) 1960-06-15

Family

ID=10342115

Family Applications (1)

Application Number Title Priority Date Filing Date
GB32662/57A Expired GB837965A (en) 1957-10-18 1957-10-18 Improvements in or relating to amines and to processes for their preparation

Country Status (1)

Country Link
GB (1) GB837965A (en)

Similar Documents

Publication Publication Date Title
DE3164764D1 (en) 1,1,2-triphenyl-but-1-ene derivatives, process for their manufacture and their use as pharmaceutical agents
TW358096B (en) Pyrazolopyridimidinone antianginal agents
ES413639A1 (en) Dopamine derivatives
GB1429751A (en) Preparations for inhibiting emesis
ES374837A1 (en) (4&#39;-(phenyl-3 6-dihydro-1-(2h)-pyridyl)-2-hydroxy propoxy-anilides and derivatives thereof
ES346521A1 (en) N-(sulfonylcarbamoyl)-bornano-(3&#39;,2&#39;:4,5)-oxazolidin-3-ones
GB989013A (en) New guanidines and process for their manufacture
GB837965A (en) Improvements in or relating to amines and to processes for their preparation
GB1061306A (en) 4-substituted-2-benzhydryl-2-butanol derivatives
ATE48994T1 (en) BENZIMIDAZOLE DERIVATIVE, PROCESS FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION.
ES482138A1 (en) Phenylpiperidine derivatives, processes for their preparation and pharmaceutical compositions containing them.
GB933504A (en) New piperidine derivatives and methods for preparing the same
ES8101646A1 (en) Optically active cephalosporin analogs, process for their preparation and their use in the preparation of pharmaceutical compositions.
GB858140A (en) The preparation of new basic phenothiazine derivatives
GB898010A (en) Process for the preparation of basic substituted carbinols
ES384946A1 (en) Novel adamantylurea derivatives and a process for the preparation thereof
GB871235A (en) Novel substituted pyrrolidones and salts thereof and a process for the manufacture of same
GB1193534A (en) Novel Benzazocine Derivatives, the Preparation thereof and Compositions Containing the same
GB843264A (en) Improvements in or relating to amines and to processes for their preparation
ES245955A1 (en) Novel tertiary amines and processes for their production
GB984364A (en) Substituted piperidines and tetrahydropyridines
GB1046001A (en) Propanolamine derivatives
NL173398B (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PROCESS FOR PREPARING A BENZENE SUBSTITUTED 1-METHYL-4-(10,11-DIHYDRO-5H-DIBENZOŸA,DŸCYCLOHEPTEN-5-YLIDEN)-PIPERIDINE DERIVATIVE.
GB1005025A (en) Naphthalene derivatives
GB863715A (en) New acylpiperidines